- Home
- ESPR vs LPRO Comparison
ESPR vs LPRO Comparison
Compare ESPR & LPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- LPRO
- Stock Information
- Founded
- ESPR 2008
- LPRO 2000
- Country
- ESPR United States
- LPRO United States
- Employees
- ESPR N/A
- LPRO N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- LPRO Finance: Consumer Services
- Sector
- ESPR Health Care
- LPRO Finance
- Exchange
- ESPR Nasdaq
- LPRO Nasdaq
- Market Cap
- ESPR 220.0M
- LPRO 252.9M
- IPO Year
- ESPR 2013
- LPRO N/A
- Fundamental
- Price
- ESPR $2.17
- LPRO $2.14
- Analyst Decision
- ESPR Buy
- LPRO Buy
- Analyst Count
- ESPR 6
- LPRO 6
- Target Price
- ESPR $6.50
- LPRO $3.00
- AVG Volume (30 Days)
- ESPR 5.2M
- LPRO 734.7K
- Earning Date
- ESPR 08-05-2025
- LPRO 08-06-2025
- Dividend Yield
- ESPR N/A
- LPRO N/A
- EPS Growth
- ESPR N/A
- LPRO N/A
- EPS
- ESPR N/A
- LPRO N/A
- Revenue
- ESPR $268,125,000.00
- LPRO $16,254,999.00
- Revenue This Year
- ESPR $6.10
- LPRO $314.67
- Revenue Next Year
- ESPR N/A
- LPRO $15.32
- P/E Ratio
- ESPR N/A
- LPRO N/A
- Revenue Growth
- ESPR N/A
- LPRO N/A
- 52 Week Low
- ESPR $0.69
- LPRO $0.70
- 52 Week High
- ESPR $3.94
- LPRO $6.92
- Technical
- Relative Strength Index (RSI)
- ESPR 73.45
- LPRO 46.85
- Support Level
- ESPR $2.00
- LPRO $1.97
- Resistance Level
- ESPR $2.14
- LPRO $2.16
- Average True Range (ATR)
- ESPR 0.15
- LPRO 0.15
- MACD
- ESPR 0.02
- LPRO -0.01
- Stochastic Oscillator
- ESPR 95.08
- LPRO 32.11
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About LPRO Open Lending Corporation
Open Lending Corp is engaged in providing automated lending services to financial institutions. The company offers loan analytics, risk-based pricing, risk modeling, and automated decision technology. Its Lenders Protection Program ("LPP") enables automotive lenders to make loans that are largely insured against, losses from defaults.